Boston Scientific to Participate in 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference

 

MARLBOROUGH, Mass., Dec. 3, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018 in New York City.

Susie Lisa, vice president, Investor Relations and Lindsay Fish, director, Investor Relations, will participate in a 35-minute question-and-answer session with the host analyst beginning at approximately 11:20 a.m. EST.  A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

Media:                                            

Investors:

Kate Haranis                                      

Susie Lisa, CFA

508-683-6585 (office)                         

508- 683-5565 (office)

Media Relations                                  

Investor Relations

Boston Scientific Corporation               

Boston Scientific Corporation

Kate.Haranis@bsci.com                      

BSXInvestorRelations@bsci.com

 

Cision View original content:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-2018-bmo-capital-markets-prescriptions-for-success-healthcare-conference-300758874.html

SOURCE Boston Scientific Corporation

 
 
Company Codes: NYSE:BSX
 

Back to news